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Background: Overviews of systematic reviews (overviews) attempt to systematically retrieve and summarize the results
of multiple systematic reviews (SRs) for a given condition or public health problem. Two prior descriptive analyses
of overviews found substantial variation in the methodological approaches used in overviews, and deficiencies in
reporting of key methodological steps. Since then, new methods have been developed so it is timely to update
the prior descriptive analyses. The objectives are to: (1) investigate the epidemiological, descriptive, and reporting
characteristics of a random sample of 100 overviews published from 2012 to 2016 and (2) compare these recently
published overviews (2012–2016) to those published prior to 2012 (based on the prior descriptive analyses).
Methods: Medline, EMBASE, and CDSR will be searched for overviews published 2012–2016, using a validated search
filter for overviews. Only overviews written in English will be included. All titles and abstracts will be screened by one
review author; those deemed not relevant will be verified by a second person for exclusion. Full-texts will be assessed
for inclusion by two reviewers independently. Of those deemed relevant, a random sample of 100 overviews will be
selected for inclusion. Data extraction will be either performed by one reviewer with verification by a second reviewer
or by one reviewer only depending on the complexity of the item. Discrepancies at any stage will be resolved by
consensus or consulting a third person. Data will be extracted on the epidemiological, descriptive, and reporting
characteristics of each overview. Data will be analyzed descriptively. When data are available for both time points (up
to 2011 vs. 2012–2016), we will compare characteristics by calculating risk ratios or applying the Mann-Whitney test.
Discussion: Overviews are becoming increasingly valuable evidence syntheses, and the number of published
overviews is increasing. However, former analyses found limitations in the conduct and reporting of overviews.
This update of a recent sample of overviews will inform whether this has changed, while also identifying areas
for further improvement.
Systematic review registration: The review will not be registered in PROSPERO as it does not meet the
eligibility criterion of dealing with health-related outcomes.
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Background
Overviews of systematic reviews (overviews) attempt to
systematically retrieve and summarize the results of
multiple systematic reviews (SRs) for a given condition
or public health problem [1]. The number of published
overviews has increased steadily in recent years [2, 3].
The Cochrane Collaboration produces overviews, and
the number of published protocols and completed over-
views in the Cochrane Database of Systematic Reviews
(CDSR) has risen to 28 and 26, respectively, at the time
of writing (16 December 2016). A preliminary search
(conducted on 16 December 2016) in Medline searching
“review of reviews”[ti] OR “overview of reviews”[ti]
resulted in 92 hits when the search was restricted to the
last 5 years, compared to 65 hits before that time range.
Two prior descriptive analyses of overviews found
substantial variation in the methodological approaches
used in overviews, and deficiencies in reporting of key
methodological steps [2, 3]. In both analyses, the most
recent fully searched year was 2011. Thus, their findings
might no longer be up-to-date.
Since these two descriptive analyses were published,
new methods for conducting overviews have been devel-
oped or tested, such as methods for dealing with multiple
SRs published on the same topic area [4] and methods for
displaying outcome data in overviews [5]. Additionally, a
new tool to assess the risk of bias in SRs called ROBIS has
been published [6]. Reporting quality of SRs has also
improved [7–10], and since many reporting items are
similar for SRs and overviews an increase in the reporting,
quality of overviews might also be expected. Furthermore,
a scoping review summarizing existing guidance for
conducting overviews of healthcare interventions was
recently published [11], and the chapter on overviews in
the Cochrane Handbook for Systematic Reviews of Inter-
ventions [1] is currently being updated. Both documents
provide new guidance on how to conduct overviews, and
it can be expected that both guidance documents will be
used by authors publishing overviews both in and outside
of the CDSR (“Cochrane overviews” and “non-Cochrane
overviews”, respectively). This is likely to have an impact
on the conduct and reporting of future overviews.
We are not aware of any other analyses describing the
characteristics of a recent sample of overviews. There-
fore, we considered it timely to update the two prior
descriptive analyses conducted by Hartling et al. [2]
and Pieper et al. [3].
Objectives
Our objectives are to: (1) investigate the epidemiological,
descriptive, and reporting characteristics of a random
sample of overviews published from 2012 to 2016
and (2) compare these recently published overviews(2012–2016) to those published prior to 2012 and
previously described [1, 2].
Methods
Eligibility criteria
Studies will be selected according to the criteria outlined
below.
Study designs
To be included in this study, an overview needs to meet
the following criteria (modified from [11]):
1) Contain a clearly formulated objective designed
to answer a specific research question about a
healthcare intervention.
2) Search for and include only SRs (with or without
meta-analyses). Note that supplementary searches
for primary studies may also be conducted to
overcome a deficiency in the SRs identified (e.g.,
to update an outdated SR, to search for evidence on
an important topic not covered in any included SR).
3) Use explicit and reproducible methods to identify
relevant SRs that meet their inclusion criteria (e.g.,
systematic literature search, screening, inclusion).
4) Collect, analyze, and present descriptive and outcome
data from the included SRs.
Protocols will be excluded. In cases where updates were
published, we will use the most recent version. Overviews
embedded within larger health technology assessments or
guidelines will be excluded.
Language
We will include overviews written in English due to
resource constraints.
Publication date
We will include overviews published between January
2012 and December 2016 (either printed or electronic).
Information sources and search strategy
We will search Medline, EMBASE, and the CDSR. Medline
via OVID will be searched using a validated search filter for
overviews [12]. The same search filter will be adapted to
EMBASE via OVID. CDSR via Cochrane Library will be
searched using the term “overview” restricted to the title,
abstract, and keywords. The search strategy will be limited
to the publication years 2012–2016. Searches for gray
literature will not be performed as we are interested in
published overviews.
Data management
The search results will be uploaded and managed using
Microsoft Excel.
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All titles and abstracts will be screened by one review
author; those deemed not relevant will be verified by a
second person for exclusion (liberal acceleration). Full-
texts of all potentially relevant articles and those without
an available abstract will be assessed for inclusion by
two reviewers independently. Discrepancies will be resolved
by consensus or consulting a third person. We will record
the reasons for exclusion and report the study selection
process using the PRISMA flow diagram [13]. An a priori
decision was made to select a random sample of 100 over-
views for inclusion in this methods study. Overviews will
be selected from the set of screened eligible overviews using
the RAND function in Microsoft Excel.
Data collection process
Prior to data extraction, a data extraction form will be
created and tested by the reviewers using a set of five of
the 100 included overviews. The extraction form will be
modified based on feedback from the reviewers to im-
prove its usability and comprehensibility. To ensure
consistency across reviewers, we will conduct calibration
exercises before starting data extraction. Data extraction
will begin when substantial agreement has been achieved
(kappa statistic ≥0.60) [14]. Data extraction will be per-
formed by one reviewer and verified by a second for
quality assurance. This will be applied to all items
deemed to be difficult in their content (e.g., due to their
subjective judgment) among the reviewers after having
extracted data on the first five overviews mentioned
above. All discrepancies between reviewers will be resolved
via consensus or involvement of a third person. For all
remaining items, single data extraction will be performed.
Data items
The data extraction items will be based on those re-
ported in Hartling et al. [2] and Pieper et al. [3] to
allow for comparisons. In particular, we will collect
data on: journal name, journal type (general vs. spe-
cialty), journal impact factor in the year of publication,
year of publication, number of authors, country of
corresponding author, registration (e.g., PROSPERO),
protocol availability (as mentioned or referenced by
the authors), topic area (based on International Classifica-
tion of Diseases-10 (ICD-10)), type of intervention examined
(pharmacological, non-pharmacological, both), inclu-
sion criteria clearly stated, primary outcomes stated,
number of databases searched, search restrictions (lan-
guage, date, publication status), selection methods, number
of included studies (SRs and primary studies), characteris-
tics of included SRs, data extraction methods, quality and
risk of bias assessment of individual studies, quality and risk
of bias assessment of systematic reviews, strategies to deal
with discordant reviews, update strategies (e.g., searchingfor primary studies published after the most recent review),
strategies for dealing with overlapping reviews, grading of
evidence, synthesis, analysis (qualitative vs. quantitative),
presentation of results (e.g., harvest plots, vote counting,
conceptual frameworks), publication bias, source(s) of
funding (Cochrane, academic, government, non-profit
organization, industry, other, no funding), and con-
flicts/declaration of interest.
Quality assessment
The overall quality of the included overviews will not be
assessed, as there is currently no validated tool available
to assess the methodological quality of overviews. Fur-
ther, our data extraction elements listed above include
features of methodological (and reporting) quality.
Data synthesis
Descriptive analyses will be performed using Microsoft
Excel software. The analysis will be descriptive, with data
summarized as frequencies for categorical items or medians
and interquartile ranges for continuous items.
When data are available for both time points, we will
also compare the epidemiological, descriptive, and report-
ing characteristics of the overviews in our sample to the
overviews published up to 2011 (contained in the descrip-
tive analyses by Hartling et al. [2] and Pieper et al. [3]).
For categorical items, we will calculate the risk ratio, with
95% confidence intervals. The risk ratio is more intuitively
interpretable than the odds ratio [15]. For continuous
items, we will apply the Mann-Whitney test to compare
medians [16]. These analyses will be performed using
SPSS Statistics v.21.0 (IBM Corp., Armonk, NY, USA).
Prior to this, we will merge both data sets from Hartling
et al. [2] and Pieper et al. [3]. The merged data set will be
checked to ensure that all included overviews meet the
same inclusion criteria outlined in this protocol. The data
for overviews included in both data sets will be checked
for consistency. Both steps will be performed by one
reviewer and verified by a second reviewer. Any dis-
agreements will be resolved via discussion.
We have not planned any subgroup analyses a priori.
However, we may decide to perform post hoc subgroup
analyses (e.g., overviews with versus without a protocol)
given appropriate numbers per group. They will be
determined in consultation with a statistician.
Discussion
Overviews have become valuable evidence syntheses in
the last few years. This is supported by their increasing
numbers. Despite the growing interest in overviews,
former descriptive analyses found substantial variation in
their methodological approaches and reporting quality,
thus potentially limiting the credibility and confidence
that clinical and policy decision-makers can place in the
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credibility and confidence are necessary for overviews
to serve as a useful tool for decision-makers. This update
will describe the epidemiology and reporting characteris-
tics of a sample of recently published overviews, while also
identifying areas for further improvement in their conduct
and reporting. Finally, this work will assist with the devel-
opment and refinement of guidance for the conduct and
reporting of overviews.Presenting and reporting the results
This protocol adheres to the Preferred Reporting Items
for Systematic Review and Meta-Analysis-Protocols
(PRISMA-P) [17]. As PRISMA-P aims to guide the de-
velopment of protocols for SRs evaluating therapeutic
efficacy, we deviated from the original checklist by
omitting items (e.g., outcomes and prioritization) due
to the methodological focus of our planned SR.
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